Market brief — September 24, 2026

Yesterday, the major equity benchmarks closed lower on the proprietary tape: the CAC 40 finished at 8,123.41 (-0.19%), the S&P 500 at 7,706.03 (-0.76%), the Nasdaq at 26,936.04 (-0.69%), the DAX at 25,410.63 (-0.64%), and the Euro Stoxx 50 at 6,299.82 (-0.29%), while the dominant macro driver remained a rates shock rather than growth optimism. The move fits a broader repricing in which U.S. Treasury yields pushed higher across the curve on the back of firmer inflation/rate-hike expectations, with Reuters reporting on September 24 that the U.S. 10-year yield held around 5.11% after briefly touching its highest since 2007, and that a stronger manufacturing print plus a weak five-year Treasury auction reinforced the bond selloff^[1][2][3]. That is not a clean risk-on tape; it is a positioning unwind and duration de-risking that is pressuring long-duration equities more than cyclical value.

The cross-asset message is still consistent: higher yields, a firm dollar and unstable duration expectations are doing the heavy lifting, while commodity moves are adding to macro noise rather than offsetting it. Reuters said the dollar was clinging to a two-month high as hot PMI data and the poor auction revived hawkish Fed bets, and it also flagged that Japan’s 10-year yield climbed to 3.06%, the highest since 1996, underscoring that this is a global rates repricing, not a U.S.-only episode^[3][1]. The key divergence is that equities are not being sold because of collapsing growth; they are being sold because the discount rate is moving against them. That typically hurts systematic and crowded momentum exposures first, then forces discretionary holders to cut beta if yields keep rising.

Today’s Cash Scanner reinforces that read but also shows where relative strength is trying to re-emerge. The strongest signal is still in rate-sensitive and balance-sheet-supported names: LTC Prop REIT Rg (LTC) scored 38 with a +9.0% gap and a 20-day breakout on strong ADX, while Thermo Fisher Scientific Inc (TMO) scored 34 with a +1.0% move and a 20-day breakout, suggesting defensive growth and quality healthcare/life-science exposure is attracting buyers even as rates rise. On the risk-on side, Palantir Tchnl-A Rg (PLTR) scored 33 and rose 3.7% on a breakout with bullish MACD and volume, and Rubrik Inc (RBRK) scored 34 with a +2.3% move on a breakout, showing that U.S. technology momentum has not broken yet. By contrast, 10X Genomics Inc-Class A (TXG) scored 35 but fell 4.4% despite strong ADX, a sign that the life-sciences complex remains bifurcated. The scanner is therefore not broad-based cyclicals leadership; it is a mix of defensive duration, selective U.S. software momentum, and pockets of speculative or crypto-linked volatility.

Over the next 1–5 sessions, the dominant narrative is likely to remain “higher-for-longer means higher real-rate pain,” with the market trying to decide whether the current Treasury selloff is a temporary auction-driven shock or the start of a more durable policy re-pricing. Consensus still appears to assume that growth can absorb tighter financial conditions, but what is already priced in is a materially higher yield curve and a stronger dollar; what is not fully settled is whether the Fed will need to lean against renewed inflation pressure. A credible contrarian scenario is that the bond selloff exhausts itself after positioning gets washed out, allowing equities to stabilize even without a macro-friendly catalyst.

The most important upcoming catalysts are the next major U.S. macro releases and any fresh Fed communication, because they will determine whether the move in front-end yields is validated or fades. Japan’s bond market is also a key cross-asset catalyst after the steep move in local yields, as further JGB stress could keep global duration under pressure. Any additional weak Treasury auction would matter immediately because it would confirm liquidity fragility rather than just hawkish repricing. If oil extends higher, that would tighten the inflation narrative further and keep pressure on rate-sensitive sectors.

The main risks are a disorderly continuation in Treasury yields, a dollar squeeze that forces further global risk reduction, and a second-round selloff in long-duration growth names if rate volatility persists. Another underappreciated risk is that bond-market stress spills into credit and then into equity multiples faster than earnings estimates can adjust.

The actionable setup is to stay constructive only if the 10-year U.S. yield fails to hold above the 5% area and the dollar stops making new highs; that would give PLTR, RBRK, and TMO room to extend without a further multiple reset. If the 10-year remains above 5% and the five-year stays above 5%, the path of least resistance is continued pressure on Nasdaq leadership and on lower-quality growth such as TXG. If oil keeps firming while yields rise, treat that as the most dangerous combination for equity duration and for the Euro Stoxx 50’s relative resilience. Bonne journée aux p&l makers.